BioCryst Announces Berotralstat Expanded Access Program for Patients with Hereditary Angioedema in United States
RESEARCH TRIANGLE PARK, N.C., June 09, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has […]